EVAX: Evaxion Biotech A/S Stocks News on November 21, 2024

EVAX

GlobeNewswire

8 days ago

Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing

EVAX

Zacks Small Cap Research

9 days ago

EVAX Racks up Positive Test Results

EVAX

GlobeNewswire

9 days ago

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1

EVAX

GlobeNewswire

21 days ago

Evaxion announces business update and third quarter 2024 financial results

EVAX

Zacks Small Cap Research

22 days ago

EVAX Exceeds Estimates and Confirms Partnership

EVAX

GlobeNewswire

24 days ago

Evaxion to announce business update and third quarter 2024 financial results on October 31

EVAX

Zacks Small Cap Research

a month ago

OTC Markets Hosts Virtual Investor Presentation with Christian Kanstrup, CEO of Evaxion Biotech, and Brad Sorensen, Senior Analyst at Zacks SCR

EVAX

GlobeNewswire

a month ago

Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials

EVAX

TipRanks

2 months ago

Evaxion Biotech Charts Future with Innovative Immune Therapies

EVAX

Zacks Small Cap Research

2 months ago

AI from EVAX Improves Trial Results

EVAX

GlobeNewswire

2 months ago

Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform

EVAX

MT Newswires

2 months ago

Evaxion Biotech Grants Merck Option to License Vaccine Candidates

EVAX

GlobeNewswire

2 months ago

Evaxion significantly expands vaccine development collaboration with MSD

EVAX

Zacks Small Cap Research

2 months ago

EVAX Process Continues to Garner Interest and Investment

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

EVAX

GlobeNewswire

2 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

EVAX

GlobeNewswire

2 months ago

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

EVAX

GlobeNewswire

2 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

EVAX

GlobeNewswire

2 months ago

Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-01

EVAX

GlobeNewswire

2 months ago

Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01

EVAX

GlobeNewswire

2 months ago

Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2

EVAX

Zacks Small Cap Research

2 months ago

EVAX Uses AI Platform to Generate Positive Treatment Data

EVAX

Simply Wall St.

3 months ago

Evaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near?

EVAX

Zacks Small Cap Research

3 months ago

EVAX is a Clinical Stage AI Company Worth a Look

EVAX

GlobeNewswire

3 months ago

Evaxion Announces Business Update and Second Quarter 2024 Financial Results

EVAX

GlobeNewswire

3 months ago

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14

EVAX

GlobeNewswire

3 months ago

Evaxion to Present One-Year Clinical Efficacy Data from its Phase 2 Study on Lead Cancer Vaccine Candidate, EVX-01, at the ESMO Congress 2024 in September

EVAX

Zacks Small Cap Research

4 months ago

EVAX: Initiating Coverage of Evaxion

EVAX

GlobeNewswire

4 months ago

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference

EVAX

GlobeNewswire

5 months ago

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

EVAX

GlobeNewswire

5 months ago

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method

EVAX

GlobeNewswire

5 months ago

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

EVAX

Zacks

5 months ago

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now

Lotto 6/49 - $64 million up for grabs in the next draw!

EVAX

CNW Group

5 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

EVAX

Simply Wall St.

5 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

EVAX

AFP

5 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

EVAX

Simply Wall St.

5 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

EVAX

Simply Wall St.

5 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

EVAX

Barrons.com

5 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

EVAX

Simply Wall St.

5 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

EVAX

Simply Wall St.

5 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

EVAX

GlobeNewswire

6 months ago

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

EVAX

GlobeNewswire

6 months ago

Evaxion Announces Business Update and First Quarter 2024 Financial Results

EVAX

MT Newswires

6 months ago

Evaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination Treatment

EVAX

GlobeNewswire

6 months ago

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

EVAX

GlobeNewswire

6 months ago

Evaxion Receives Nasdaq Notification

Sidoti Events, LLC's Virtual May Micro-Cap Conference

EVAX

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

EVAX

GlobeNewswire

7 months ago

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

EVAX

Zacks

8 months ago

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data

EVAX

Insider Monkey

8 months ago

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript

EVAX

GlobeNewswire

8 months ago

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

EVAX

GlobeNewswire

8 months ago

Evaxion Announces Business Update and Full Year 2023 Financial Results

EVAX

Simply Wall St.

8 months ago

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?

EVAX

GlobeNewswire

8 months ago

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

EVAX

GlobeNewswire

9 months ago

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

EVAX

GlobeNewswire

9 months ago

Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD

EVAX

GlobeNewswire

9 months ago

Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement

EVAX

GlobeNewswire

9 months ago

Evaxion Announces Closing of $15 Million Public Offering

EVAX

GlobeNewswire

10 months ago

Evaxion Biotech Announces Pricing of $15 Million Public Offering

EVAX

GlobeNewswire

10 months ago

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

EVAX

GlobeNewswire

10 months ago

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

EVAX

GlobeNewswire

10 months ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

EVAX

GlobeNewswire

10 months ago

Evaxion Announces Completion of ADS Ratio Change

EVAX

Business Wire

10 months ago

TransAct Announces BOHA! Solutions Order from Regional Assisted Living Communities

EVAX

Zacks Small Cap Research

10 months ago

CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

EVAX

GlobeNewswire

10 months ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

EVAX

GlobeNewswire

10 months ago

Evaxion Announces Plan to Implement ADS Ratio Change

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

EVAX

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Forian Inc. (NASDAQ:FORA) insiders have recently purchased stock and their bets paid off last week as company hit US$112m market cap

EVAX

Simply Wall St.

a year ago

Forian Inc. (NASDAQ:FORA) insiders have recently purchased stock and their bets paid off last week as company hit US$112m market cap

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

EVAX

GlobeNewswire

a year ago

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

EVAX

PR Newswire

a year ago

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

EVAX

GlobeNewswire

a year ago

Evaxion Biotech Announces Closing of Private Placement

EVAX

GlobeNewswire

a year ago

Evaxion Announces Business Update and Third Quarter 2023 Financial Results

EVAX

GlobeNewswire

a year ago

Evaxion Biotech Announces Private Placement Financing

Insider Spends US$100k Buying More Shares In Cytosorbents

EVAX

Simply Wall St.

a year ago

Insider Spends US$100k Buying More Shares In Cytosorbents

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)

EVAX

GuruFocus.com

a year ago

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

EVAX

GlobeNewswire

a year ago

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

Greenland Technologies to Present at Water Tower Research Investor Conference

EVAX

PR Newswire

a year ago

Greenland Technologies to Present at Water Tower Research Investor Conference

LightPath Announces Initial $4.7m Order from Lockheed Martin

EVAX

ACCESSWIRE

a year ago

LightPath Announces Initial $4.7m Order from Lockheed Martin

LightPath Technologies Schedules Annual Meeting of Stockholders

EVAX

ACCESSWIRE

a year ago

LightPath Technologies Schedules Annual Meeting of Stockholders

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

EVAX

ACCESSWIRE

a year ago

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

EVAX

GlobeNewswire

a year ago

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

EVAX

GlobeNewswire

a year ago

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

LightPath Technologies Postpones Annual Meeting of Stockholders

EVAX

ACCESSWIRE

a year ago

LightPath Technologies Postpones Annual Meeting of Stockholders

LightPath Technologies, Inc. (NASDAQ:LPTH) Q1 2024 Earnings Call Transcript

EVAX

Insider Monkey

a year ago

Latest Evaxion Biotech A/S (EVAX) News on November 21, 2024

Share on Social Networks: